Back to results
US 2024/0325518 A1Published application
Method for inactivating zika virus and for determining the completeness of inactivation
AssigneeTakeda Vaccines, Inc.
InventorsJill A. LIVENGOOD, Holli GIEBLER, Hansi DEAN, Tatsuki SATOU, Raman RAO, Jackie MARKS, Mark LYONS, Asae SHINTANI, James GIFFORD, Sushma Kommareddy
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods for inactivating a Zika virus which can be used in vaccines and immunogenic compositions. The present disclosure also relates to a method for determining the completeness of inactivation of an arbovirus preparation.
Claims21
1-36. (Cancelled)
A pharmaceutical composition comprising an inactivated Zika virus and having a residual formaldehyde content of less than 50 μg/mL.
Dependencies are inferred from the claim text.